BNL Input Market overview
Number of employees:
Philip Morris Benelux BVBA: 178
Philip Morris Holland B.V. 293
Our main brands include Marlboro, the number one brand in the Benelux, L&M and Chesterfield.
Philip Morris International Inc (“PMI”) has three subsidiaries in the Benelux: Philip Morris Benelux BVBA established in 1971, Philip Morris Holland B.V. established in 1969, and Philip Morris Luxembourg established in 1969.
Philip Morris Benelux BVBA is based in Antwerp, Belgium, and responsible for marketing and sales of Philip Morris Benelux BVBA products.
Philip Morris Holland B.V. (“PMH”) consists of the Bergen op Zoom production facility, where we produce semi-manufactured goods for the production of cigarettes in other PMI factories. The site also contains a flavour centre and serves as logistical hub. Further, the Dutch Sales Organization is part of PMH.
In June 2016, PMH announced that Philip Morris International Inc, PMH’s parent company, is planning to invest €65 million in Bergen op Zoom to install two new production lines for the manufacturing of the tobacco sheet used in its “HeatSticks”, an innovative heated tobacco product.
PMI attaches great importance to top-quality working conditions for its employees, as well as skills enhancement. In reward for its commitment, the Company was recognized in 2016 by the international certification firm Top Employers Institute as “Top Employer Holland”, “Top Employer Belgium” and “Top Employer Europe”.
Smoking and Health
Tobacco products, including cigarettes, are dangerous and addictive. There is overwhelming medical and scientific evidence that smoking causes lung cancer, heart disease, emphysema, and other serious diseases.
All tobacco products are addictive. It can be very difficult to quit smoking, but this should not deter smokers who want to quit from trying to do so.
Public health officials have concluded that secondhand smoke from cigarettes causes serious diseases in non-smokers, including lung cancer and heart disease. We believe the public health conclusions on secondhand smoke are sufficient to support smoking restrictions in public places.
Philip Morris International (PMI) supports comprehensive regulation of tobacco products based on the principle of harm reduction.
To be effective, tobacco regulatory policy must be evidence-based, apply to all tobacco products, and should take into account the views of all legitimate stakeholders including public health authorities, government finance authorities, tobacco manufacturers, and other members of the tobacco supply chain. Regulatory policy must consider the potential to trigger adverse consequences which undermine public health objectives, such as increasing the demand for illicit cigarettes.
While we support comprehensive, effective tobacco regulation, we do not support regulation that prevents adults from buying and using tobacco products or that imposes unnecessary impediments to the operation of the legitimate tobacco market. In that regard, we oppose measures such as generic packaging, point of sale display bans, total bans on communications to adult consumers, and bans on the use of all ingredients in tobacco products.